Explore the Global Monkeypox Treatment Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Monkeypox Treatment Market

Key Insight

Monkeypox treatment sales will grow through 2036, led by therapeutic treatments at 68.4% of the treatment type segment in 2026. The market is projected to grow from USD 125.5 million in 2026 to USD 325.4 million by 2036, creating an incremental opportunity of USD 199.96 million between 2026 and 2036.

April 22, 2026

Anurag Sharma

290 Pages

Cite this Report

Monkeypox Treatment Market

https://www.futuremarketinsights.com/reports/monkeypox-treatment-market

License

Starting at US$ 5000

Buy Now

Summary ToC Infographics Companies

Key Players

Bavarian Nordic
Chimerix
Emcure Pharmaceuticals Ltd
Emergent Pharmaceuticals
Gilead Sciences
Hetero
Jinan Jinda Pharmaceutical Chemistry Co. Ltd
Piramal Pharma Solutions
SIGA Technologies Inc
L'Oréal

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Monkeypox Treatment Market

Key Players

Similar Industry Reports